Advanced Search

RS 0.451.431 Cartagena Protocol of 29 January 2000 on Biosafety to the Convention on Biological Diversity (with annexes)

Original Language Title: RS 0.451.431 Protocole de Cartagena du 29 janvier 2000 sur la prévention des risques biotechnologiques relatif à la Convention sur la diversité biologique (avec annexes)

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.

0.451.431

Original text

Cartagena Protocol on Biosafety to the Convention on Biological Diversity

Conclu à Montréal January 29, 2000

Approved by the Federal Assembly on March 4, 2002 1

Instrument of ratification deposited by Switzerland on 26 March 2003

Entered into force for Switzerland on 11 September 2003

(Status on 3 February 2015)

The Parties to this Protocol,

Being Parties to the Convention of 5 June 1992 on Biological Diversity 2 Hereinafter referred to as "the Convention",

Recalling paras. 3 and 4 of Art. 19, art. 8 G And art. 17 of the Convention,

Recalling also decision II/5 of 17 November 1995 of the Conference of the Parties to the Convention requesting the elaboration of a protocol on the prevention of biotechnological risks that would specifically address transboundary movements Modified living organisms resulting from modern biotechnology which may have adverse effects on the conservation and sustainable use of biological diversity, and which would consider, in particular, an appropriate procedure for agreement Prior knowledge of cause,

Reaffirming the precautionary approach enshrined in Principle 15 of the Rio Declaration on Environment and Development,

Aware that modern biotechnology is developing rapidly and that the general public is increasingly concerned about the adverse effects it may have on biological diversity, including the risks that it could entail for the Human health,

Recognising that modern biotechnology offers considerable potential for human well-being as long as it is developed and used in safe conditions for the environment and human health,

Conscious also of the crucial importance to humanity of the centres of origin and the centres of genetic diversity,

Taking into account the fact that many countries, including developing countries, have limited means to deal with the nature and extent of the known and potential risks of living modified organisms,

Believing that trade and environment agreements should be mutually supportive with a view to achieving sustainable development,

Underlining that this Protocol shall not be construed as implying any change in the rights and obligations of a Party under other international agreements in force,

Whereas it is understood that the present preamble is not intended to subordinate the Protocol to other international agreements,

Agreed to the following:

Art. 1 Objectives

In accordance with the precautionary approach enshrined in Principle 15 of the Rio Declaration on Environment and Development, the objective of this Protocol is to contribute to ensuring an adequate level of protection for transfer, Safe handling and use of living modified organisms resulting from modern biotechnology that may have adverse effects on the conservation and sustainable use of biological diversity, also taking into account Risks to human health, with a specific focus on movements Transborder.

Art. 2 General provisions

Each Party shall take the necessary and appropriate legal, administrative and other measures to fulfil its obligations under the Protocol.

2. The Parties shall ensure that the development, handling, transport, use, transfer and release of any living modified organism is done in such a way as to prevent or reduce the risks to biological diversity, in Also taking into account the risks to human health.

Nothing in this Protocol shall affect, in any way, the sovereignty of States over their territorial waters as established under international law or the sovereign rights or jurisdiction exercised by them in their area And on their continental shelf under international law or the exercise by ships and aircraft of all States of the rights and freedoms of navigation conferred by international law and enshrined in instruments Relevant international.

Nothing in this Protocol shall be construed as restricting the right of a Party to take more stringent measures for the conservation and sustainable use of biological diversity than those provided for in the Protocol, to Condition that they are compatible with the objective and provisions of the Protocol and in accordance with the other obligations imposed on that Party by international law.

5. The Parties are encouraged to take appropriate account of the available expertise, existing instruments and the work undertaken by the relevant international bodies in relation to risks to human health.

Art. 3 Definitions

For the purposes of the Protocol:

A.
"Conference of the Parties" means the Conference of the Parties to the Convention;
B.
"Confined Use" means any operation, undertaken in a device, facility, or other physical structure, involving living modified organisms that are regulated by specific measures that Effectively limit contact with the outside world, and the impact on that environment;
C.
"Exportation" means any intentional transboundary movement from one Party to another Party;
D.
"Exporter" means any legal or natural person, within the jurisdiction of the exporting Party, who arrangs for an amended living organism to be exported;
E.
"Importation" means any intentional transboundary movement to a Party and from another Party;
F.
"Importer" means any legal or natural person, within the jurisdiction of the importing Party, who makes arrangements for an amended living organism to be imported;
G.
"Modified living organism" means any living organism that has a unique combination of genetic material obtained through the use of modern biotechnology;
H.
"Living organism" means any biological entity capable of transferring or replicating genetic material, including sterile organisms, viruses and viroids;
I.
"Modern Biotechnology" means:
A.
Of application of techniques In vitro Nucleic acids, including the recombination of deoxyribonucleic acid (DNA) and the direct introduction of nucleic acids into cells or organelles,
B.
Cell fusion of organisms not belonging to the same taxonomic family,
Which overcome the natural barriers of reproductive or recombination physiology and are not techniques used for reproduction and selection of classical type.
J.
"Regional economic integration organization" means any organization constituted by sovereign States of a given region, to which its member States have transferred their competence to all matters falling within the scope of the Protocol and which has Duly authorised, in accordance with its internal procedures, to sign, ratify, accept or approve the Protocol, or accede to it;
K.
"Transboundary Movement" means any movement of a living modified organism from a Party to another Party, except for the purposes of s. 17 and 24, "transboundary movement" extends to movements between Parties and non-Parties.
Art. 4 Scope of application

This Protocol shall apply to transboundary movements, transit, handling and use of any living modified organism which may have adverse effects on the conservation and sustainable use of diversity Also taking into account the risks to human health.

Art. 5 Pharmaceuticals

Notwithstanding Art. 4 and without prejudice to the right of the Parties to submit any living modified organism to a risk assessment before taking a decision on its importation, this Protocol shall not apply to transboundary movements of organisms Living modified products that are pharmaceuticals for human use under other relevant international agreements or bodies.

Art. 6 Confined Transit and Use

1. Notwithstanding s. 4 and without prejudice to the right of a transit Party to regulate the transport of living modified organisms on its territory and to notify the Biosafety Clearing-Office of any decision it has taken, pursuant to From s. 3 of Art. 2, concerning transit in its territory of a specified living modified organism, the provisions of this Protocol concerning the prior informed consent procedure shall not apply to living modified organisms in transit.

2. Notwithstanding s. 4 and without prejudice to the right of any Party to submit a living modified organism regardless of its risk assessment before taking a decision on its importation and setting standards for environmental uses Confined within the limits of its jurisdiction, the provisions of this Protocol relating to the prior informed consent procedure shall not apply to transboundary movements of living modified organisms intended to be Used in a confined environment that is carried out in accordance with the standards of the importing Party.

Art. 7 Application of the prior informed consent procedure

1. Subject to s. 5 and 6, the prior informed consent procedure under Art. 8, 9, 10 and 12 applies before the first intentional transboundary movement of living modified organisms intended to be intentionally introduced into the environment of the importing Party.

2. The intentional introduction into the environment referred to in s. 1 above does not apply to living modified organisms intended to be used directly for food or feed, or to be processed.

3. Art. 11 applies before the first transboundary movement of living modified organisms intended for use directly for human or animal feed or for processing.

4. The prior informed consent procedure shall not apply to intentional transboundary movements of living modified organisms which, in a decision of the Conference of the Parties serving as the Meeting of the Parties to the Protocol, are defined as unlikely to have adverse effects on the conservation and sustainable use of biological diversity, taking into account also the risks to human health.

Art. 8 Notification

1. The exporting Party shall address, or require the exporter to notify, in writing, to the competent national authority of the importing Party, a notification prior to the intentional transboundary movement of a living modified organism referred to in the By. 1 of the art. 7. The notification shall contain at least the information specified in Annex I.

2. The exporting Party shall ensure that there is legal responsibility for the accuracy of the information provided by the exporter.

Art. Acknowledgement of Notification

The importing Party shall, in writing, send to the author of the notification, within ninety days, an acknowledgement of receipt of the notification.

2. The acknowledgement indicates:

A.
The date of receipt of the notification;
B.
If the notification contains at first sight the information referred to in Art. 8;
C.
Whether to proceed in accordance with the importing Party's domestic regulatory framework or in accordance with the procedure set out in s. 10.

3. The national regulatory framework referred to in s. 2, para. c, above shall be in conformity with the Protocol.

4. The fact, for the importing Party, not to acknowledge receipt of a notification, does not mean that it consents to the intentional transboundary movement.

Art. 10 Decision Procedure

1. The decisions taken by the importing Party shall be in accordance with Art. 15.

(2) The importing Party shall, within the period prescribed in s. 9, indicate in writing to the notifier whether the intentional transboundary movement may take place:

A.
Only when the importing Party has given its consent in writing; or
B.
After a period of at least ninety days without further written consent.

3. Within two hundred and seventy days from the date of receipt of the notification, the importing Party shall communicate in writing, to the notifier and the Biosafety Clearing-Centre, the relevant decision To par. 2, para. a, above:

A.
Authorizing the importation, with or without condition, and indicating how the decision will apply to subsequent importations of the same living modified organism;
B.
Prohibiting imports;
C.
Requesting additional relevant information in accordance with its national regulations or Schedule I; the number of days that elapse between the time the importing Party requests additional relevant information; and It does not take them into account in calculating the period of time available to it to respond;
D.
Informing the notifier that the period specified in this paragraph is extended for a specified period of time.

4. Except in the case of unconditional consent, the decisions referred to in s. 3 above shall indicate the reasons for the reasons.

5. The fact, for the importing Party, not to communicate its decision within two hundred and seventy days after the date of receipt of the notification does not mean that it consents to the intentional transboundary movement.

The lack of scientific certainty due to insufficient scientific information and knowledge concerning the extent of the potential adverse effects of an altered living organism on the conservation and sustainable use of Biological diversity in the importing Party, also taking into account the risks to human health, does not prevent this Party from taking the appropriate decision concerning the importation of the living modified organism as Indicated in par. 3 above, to avoid or minimize these potential adverse effects.

The Conference of the Parties serving as the Meeting of the Parties to the Protocol shall, at its first meeting, decide on appropriate procedures and mechanisms to assist the importing Parties in making a decision.

Art. 11 Procedure for living modified organisms intended for use directly for human or animal feed or for processing

1. Any Party which makes a final decision concerning the use in the national territory, including the placing on the market, of a living modified organism which may be the subject of a transboundary movement and which is intended to be used Directly for human or animal feed or to be processed, shall, within 15 days thereafter, inform the other Parties, through the Biotechnology Risk Prevention Centre. This information shall contain at least the information requested in Annex II. The Party shall provide, in writing, a copy of this information to the national correspondents of the Parties who have informed the Secretariat in advance of the fact that they do not have access to the Biosafety Clearinghouse. This provision shall not apply to decisions concerning field testing.

(2) Any Party taking a decision in accordance with par. 1 above ensures that legal provisions guarantee the accuracy of the information provided by the applicant.

3. Any Party may request additional information from the authority referred to in para. B of Annex II.

(4) Any Party may take, within the framework of its national rules, a decision concerning the import of a living modified organism intended for use directly for human or animal feed or to be processed, subject to reservation That this decision be in accordance with the objective of this Protocol.

5. Each Party shall make available to the Biosafety Clearinghouse a copy of all national laws, regulations and guidelines applicable to the importation of living modified organisms intended to be Used directly for human or animal feed or to be processed, if available.

6. Any developing country or country with economies in transition Party to this Protocol may, in the absence of the national regulatory framework referred to in s. 4 above, when exercising its national competence, declare, through the Biosafety Clearing Centre, that its decision prior to the first importation of a living modified organism intended to be Used directly for human or animal feed or to be processed, for which information has been provided in application of s. 1 above will be taken:

A.
Following an assessment of the risks undertaken in accordance with Annex III; and
B.
Within a foreseeable period of time not exceeding two hundred and seventy days.

7. The fact that a Party does not communicate its decision in accordance with s. 6 above does not mean that it consents to import or refuses to import the modified living organism considered to be used directly for human or animal feed or to be processed, unless it has specified it Also.

The lack of scientific certainty due to insufficient scientific information and knowledge concerning the extent of the potential adverse effects of a living modified organism on the conservation and sustainable use of Biological diversity in the importing Party, also taking into account the risks to human health, does not prevent this Party from taking the appropriate decision concerning the importation of this living modified organism if it is intended to Be used directly for human or animal nutrition or to be used To avoid or minimize these potential adverse effects.

9. Any Party may make known its needs for financial and technical assistance and capacity development in respect of living modified organisms intended for direct use in human or animal nutrition or Be transformed. The Parties shall cooperate to meet these needs, in accordance with Art. 22 and 28 of this Protocol.

Art. 12 Review of decisions

1. An importing Party may at any time, in the light of new scientific information on the potential adverse effects on the conservation and sustainable use of biological diversity, also taking into account the risks to health Review and modify its decision on intentional transboundary movement. In such a case, within 30 days, it shall inform the authors of previous notifications of movements of the living modified organism in question, as well as the Clearing Centre for Biosafety, indicating The reasons for the decision.

(2) An exporting Party or the author of a notification may request an importing Party to reconsider its decision concerning it, pursuant to s. 10, where the exporting Party or the notifier considers:

A.
There is a change in circumstances that would affect the results of the risk assessment that based the decision; or
B.
Additional scientific or technical information is available.

The importing Party shall reply in writing to that request within ninety days, indicating the reasons for its decision.

4. The importing Party may, at its discretion, require a risk assessment for subsequent imports.

Art. 13 Simplified procedure

1. An importing Party may, provided that adequate measures are applied to ensure the safe intentional transboundary movement of living modified organisms, in accordance with the objective of the Protocol, specify in advance Biotechnological Risk Prevention Clearinghouse:

A.
Cases where an intentional transboundary movement of which it is the destination may take place at the same time as the movement is notified to it;
B.
Imports of living modified organisms exempted from the prior informed consent procedure.

The notifications referred to in para. A above may be claimed for similar subsequent movements to the same Party.

2. Information concerning an intentional transboundary movement to be included in the notification referred to in s. 1, para. a, above are those indicated in Annex I.

Art. 14 Bilateral, regional and multilateral agreements and arrangements

Parties may conclude bilateral, regional and multilateral agreements and arrangements on intentional transboundary movements of living modified organisms, if they are consistent with the objective of the Protocol and provided that such Agreements and arrangements do not result in a lesser degree of protection than that provided for in the Protocol.

2. The Parties shall inform each other, through the Biotechnology Risk Prevention Exchange Centre, of any bilateral, regional or multilateral agreements or arrangements that they have concluded before or after the date of entry into Of the Protocol.

3. The provisions of the Protocol shall have no effect on intentional transboundary movements which take place under one of these agreements or arrangements between the Parties to that agreement or arrangement.

(4) Any Party may decide that its national rules shall apply to certain specific imports intended for it and shall notify its decision to the Biosafety Clearing-Office.

Art. 15 Risk Assessment

1. The risk assessments undertaken under this Protocol shall be carried out in accordance with established scientific methods, in accordance with Annex III and taking into account the methods of risk assessment recognised. These risk assessments shall be based on the information provided in accordance with Art. 8 and other available scientific evidence to determine and assess the potential adverse effects of living modified organisms on the conservation and sustainable use of biological diversity, also taking into account Risks to human health.

2. The importing Party shall ensure that a risk assessment is conducted to make a decision under s. 10. The exporter may require the exporter to carry out the risk assessment.

3. The cost of the risk assessment shall be borne by the notifier if required by the importing Party.

Art. 16 Risk Management

1. Taking into account s. 8, para. g, of the Convention, the Parties shall establish and implement appropriate mechanisms, measures and strategies to regulate, manage and control the risks identified in the provisions of the Protocol relating to the evaluation of Risks associated with the use, handling and transboundary movement of living modified organisms.

2. Measures based on risk assessment shall be imposed to the extent necessary to prevent adverse effects of the living modified organism on the conservation and sustainable use of biological diversity, including risks For human health, on the territory of the importing Party.

Each Party shall take appropriate measures to prevent unintentional transboundary movements of living modified organisms, including measures prescribing a risk assessment prior to the first release of a living organism Changed.

4. Without prejudice to s. 2 above, each Party shall ensure that any living modified, imported or locally developed organism has been subjected to an appropriate observation period corresponding to its life cycle or training time before being used as a Expected.

5. The Parties shall cooperate in order to:

A.
To identify living modified organisms or the characteristics of living modified organisms which may have adverse effects on the conservation and sustainable use of biological diversity, taking into account also risks to the Human health;
B.
Take appropriate measures to treat these living modified organisms or specific characters.
Art. 17 Unintentional transboundary movements and emergency measures

Each Party shall take appropriate measures to notify the States actually affected or may be affected, at the Biosafety Clearing-Office and, if necessary, the relevant international organizations, all Knowledge that falls within its jurisdiction and that results in a release that results in or can result in an unintentional transboundary movement of a living modified organism likely to have adverse effects Important conservation and sustainable use of biological diversity, There are also risks to human health in these states. Notification shall be given as soon as the Party concerned becomes aware of this situation.

2. Each Party shall communicate to the Biosafety Clearing Centre, no later than the date of entry into force of this Protocol in respect of that Party, the contact details of the person entitled to receive the Notifications under this Article.

3. Any notification given under s. 1 above should include the following:

A.
Any relevant information available on the estimated quantities and relevant characteristics and characteristics of living modified organisms;
B.
Information on the circumstances and expected date of release, as well as the use of the living modified organism in the Party of origin;
C.
Any available information on the potential adverse effects on the conservation and sustainable use of biological diversity, including risks to human health, as well as any available information on possible measures of Risk management;
D.
Any other relevant information;
E.
Contact information for further information.

4. In order to minimise any significant adverse effects on the conservation and sustainable use of biological diversity, also taking into account the risks to human health, each Party under the jurisdiction of the Release of the living modified organism referred to in s. 1 above shall immediately consult the States actually affected or which may be affected, in order to enable them to determine the appropriate interventions and take the necessary measures, including emergency measures.

Art. 18 Handling, transport, packaging and identification

In order to avoid adverse effects on the conservation and sustainable use of biological diversity, taking into account also the risks to human health, each Party shall take the necessary measures to require that the bodies Modified live animals which are the subject of an intentional transboundary movement under this Protocol shall be handled, packed and transported in safety conditions, taking into account relevant international rules and standards.

2. Each Party shall take measures to require that the accompanying documentation:

A.
Living modified organisms intended to be used directly for food and feed, or for processing, clearly indicates that they "may contain" living modified organisms and that they are not intended to be Intentionally introduced into the environment, and indicates contact information for further information. The Conference of the Parties serving as the Meeting of the Parties to the Protocol shall take a decision setting out in detail the terms of that obligation, in particular the manner in which the identity of such bodies and all Specific identification, no later than two years after the entry into force of the Protocol;
B.
Living modified organisms intended for use in a confined environment shall clearly indicate that they are living modified organisms, specifying the safety rules to be observed in the handling, storage, transport and use of These organizations, and indicate contact information for further information, including the name and address of the person and institution to which the living modified organisms are shipped;
C.
Living modified organisms intended to be intentionally introduced into the environment of the importing Party, as well as any other living modified organism covered by the Protocol, clearly indicate that they are living organisms Shall specify their identity and their relevant characteristics and characteristics, as well as any safety rules to be observed for the handling, storage, transport and use of such organisms, and shall indicate the contact details of the person to be Contact for any additional information, and, where applicable, the name and The address of the importer and exporter; and contain a declaration certifying that the transaction complies with the requirements of the Protocol applicable to the exporter.

3. The Conference of the Parties serving as the Meeting of the Parties to the Protocol shall determine whether it is necessary to develop standards for identification, handling, packaging and transport, and sets out the modalities for such elaboration, in Consulting with other relevant international bodies.

Art. 19 Competent national authorities and national correspondents

Each Party shall designate a national focal point to liaise with the Secretariat on its behalf. Each Party shall also designate one or more competent national authorities responsible for carrying out the administrative functions referred to in the Protocol and authorized to act on its behalf in the performance of those functions. A Party may entrust to a single entity the functions of a national correspondent and a competent national authority.

Each Party shall communicate to the Secretariat, no later than the date of entry into force of the Protocol as far as it is concerned, the names and addresses of its national correspondent and the competent national authority or authorities. Where a Party designates more than one competent national authority, it shall indicate to the Secretariat, with its notification to that effect, the respective areas of responsibility of those authorities. Where appropriate, it will at least be specified the competent authority for each type of living modified organism. Each Party shall immediately notify the Secretariat of any change in the designation of its national correspondent or of the name, address, or responsibilities of its competent national authority or authorities.

The Secretariat shall forthwith inform the Parties of the notifications received under s. 2 above and also makes this information available through the Biosafety Clearinghouse.

Art. Exchange of information and Exchange Centre for Biosafety

1. An Exchange Centre for Biosafety is established within the framework of the exchange mechanism provided for in par. 3 of Art. 18 of the Convention, for:

A.
Facilitate the exchange of scientific, technical, ecological and legal information, as well as experience, relating to living modified organisms;
B.
To assist Parties in the implementation of the Protocol, taking into account the specific needs of developing countries, including the least developed countries and small island developing States, and countries with economies in transition, as well as Countries that are centres of origin and centres of genetic diversity.

2. The Biosafety Clearinghouse is a means of making information available for the purposes identified in s. 1 above. It provides access to information relevant to the implementation of the Protocol provided by the Parties. It also provides access to other international mechanisms for the exchange of information on the prevention of biotechnological risks, if possible.

3. Without prejudice to the protection of confidential information, each Party shall communicate to the Biosafety Clearinghouse any information it is required to provide under the Protocol, and shall:

A.
All existing national laws, regulations and guidelines for the implementation of the Protocol, as well as the information required by the Parties in the context of the prior informed consent procedure;
B.
Any bilateral, regional or multilateral agreement or arrangement;
C.
A summary of risk assessments or environmental studies related to living modified organisms conducted pursuant to its regulations and conducted in accordance with s. 15, including, if necessary, relevant information concerning products derived from them, namely processed material from living modified organisms containing new detectable combinations of genetic material Replicable through the use of modern biotechnology;
D.
Its final decisions regarding the importation or release of living modified organisms;
E.
Reports submitted under s. 33, including reports on the application of the prior informed consent procedure.

4. The modalities of operation of the Biosafety Clearing-Centre, including its activity reports, shall be reviewed and adopted by the Conference of the Parties serving as the Meeting of the Parties to the Protocol to its First meeting and are subject to subsequent reviews.

Art. Confidential Information

The importing Party shall allow the author of the notification to indicate, among the information communicated in accordance with the procedures laid down in the Protocol or required by the importing Party under the agreement procedure Prior knowledge of the Protocol, those which must be considered confidential. In such cases, a justification is provided upon request.

2. The importing Party shall consult the notifier when it decides that the information considered by the Party as confidential does not meet the requirements for processing as such and, before disclosing the information, It shall inform it of its decision, stating its reasons on request and providing for the possibility of consultations and an internal review of the decision.

3. Each Party shall protect confidential information received under the Protocol, including confidential information received under the prior informed consent procedure of the Protocol. Each Party shall ensure that it has procedures in place to protect such information and to protect the confidentiality of such information in such a favorable manner as it uses for confidential information relating to Living modified organisms of national origin.

4. The importing Party shall not use this information for commercial purposes, except with the written consent of the notifier.

5. If the author of the notification withdraws or withdraws the notification, the importing Party shall respect the confidentiality of all commercial or industrial information, including information on research and development, and Confidentiality is the subject of a disagreement between that Party and the notifier.

6. Without prejudice to s. 5 above, the following information is not kept confidential:

A.
The name and address of the notifier;
B.
A general description of the living modified organism or organism;
C.
A summary of the impact risk assessment on the conservation and sustainable use of biological diversity, taking into account also the risks to human health;
D.
Emergency response procedures and plans.
Art. Capacity Building

1. The Parties shall cooperate in the development and strengthening of human resources and institutional capacity in the field of biosafety, including biotechnology insofar as it relates to Prevention of biotechnological risks, with a view to the effective implementation of the Protocol in developing country Parties, in particular in the least developed countries and small island developing States, as well as in the Parties with economies in transition, including through institutions and organizations Global, regional, sub-regional and national levels and, where appropriate, by encouraging private sector participation.

2. For the purposes of application of s. 1 above, with regard to cooperation, the needs of developing country Parties, in particular those of the least developed countries and small island developing States, in terms of financial resources, access to technology Know-how and transfer of technology and know-how in accordance with the relevant provisions of the Convention are fully taken into account in the creation of capacities for the prevention of biotechnological risks. Cooperation in capacity-building shall include, subject to differences between the situations, the means and the needs of each Party: scientific and technical training for the rational and safe use of Biotechnology and the use of risk assessments and techniques for the management of biotechnological risks, as well as the strengthening of technical and institutional capacity in the field of biosafety. The needs of Parties with economies in transition are also fully taken into account in building capacity for the prevention of biotechnological risks.

Art. Public awareness and participation

1. The Parties:

A.
Encourage and facilitate public awareness, education and participation in the safe transfer, handling and use of living modified organisms for the conservation and sustainable use of Biological diversity, also taking into account risks to human health. The Parties shall, in order to do so, cooperate, as appropriate, with other States and international bodies;
B.
Strive to ensure that public awareness and education includes access to information on living modified organisms, within the meaning of the Protocol, that can be imported.

2. The Parties shall, in accordance with their respective laws and regulations, consult the public when making decisions relating to living modified organisms and make available to the public the outcome of those decisions, while respecting the Confidentiality of information in accordance with s. 21.

Each Party shall endeavour to inform the public about the means of access to the Biosafety Clearinghouse.

Art. 24 Non-Parties

The transboundary movement of living modified organisms between Parties and non-Parties shall be consistent with the objective of the Protocol. The Parties may enter into bilateral, regional or multilateral agreements and arrangements with non-Parties on such transboundary movements.

2. The Parties shall encourage non-Parties to accede to the Protocol and to communicate to the Biosafety Clearing Centre appropriate information on living modified organisms released on their territory, or Subject to movements to or from areas within their national jurisdiction.

Art. 25 Illegal Transboundary Movements

Each Party shall adopt national measures to prevent and punish, as appropriate, transboundary movements of living modified organisms in contravention of the national measures it has taken to implement this Protocol. Such movements will be deemed to be illegal transboundary movements.

(2) In the case of an illicit transboundary movement, the affected Party may request the Party of origin to eliminate, at its own expense, the living modified organisms concerned, by repatriating or destroying them, as appropriate.

(3) Each Party shall make available to the Centre for Biosafety Clearing the information relating to the cases of illicit transboundary movements concerning it.

Art. 26 Socio-economic considerations

1. The Parties, when making an import decision under this Protocol or under the national measures they have taken to implement the Protocol, may take into account, in accordance with their obligations Socio-economic impacts of the impact of living modified organisms on the conservation and sustainable use of biological diversity, having regard to the value of biological diversity for indigenous communities and Local, in particular.

2. Parties are encouraged to cooperate in research and exchange of information on the socio-economic impact of living modified organisms, in particular for indigenous and local communities.

Art. 27 Liability and reparation

The Conference of the Parties, serving as the Meeting of the Parties to this Protocol, shall, at its first meeting, undertake a process to develop appropriate international rules and procedures for liability and reparation for Damage resulting from transboundary movements of living modified organisms, by analysing and taking due account of the ongoing work in international law on these issues, and striving to complete this process within four years.

Art. 28 Funding mechanisms and financial resources

When considering the question of financial resources for the implementation of the Protocol, the Parties shall take into account the provisions of Art. 20 of the Convention.

2. The funding mechanism established by s. 21 of the Convention is, through its institutional structure, the mechanism for the financing of the Protocol.

3. With respect to capacity-building under s. 22 of the Protocol, the Conference of the Parties serving as the Meeting of the Parties to the Protocol shall take into account, when providing guidance on the financing mechanism referred to in s. 2 above, for consideration by the Conference of the Parties, of the need for financial resources of developing country Parties, in particular the least developed countries and small island developing States.

4. Under s. 1 above, the Parties shall also take into account the needs of developing country Parties, in particular those of the least developed countries and small island developing States, as well as those of Parties with economies in transition, When they seek to identify and meet their capacity-building needs for the purposes of the Protocol.

5. The guidelines provided to the financing mechanism of the Convention in the relevant decisions of the Conference of the Parties, including those approved prior to the adoption of the Protocol, shall apply, Mutatis mutandis , the provisions of this Article.

6. Developed country Parties may also provide financial and technological resources for the implementation of the provisions of the Protocol, through bilateral, regional and multilateral arrangements, including developing countries Parties And Parties with economies in transition will be able to use them.

Art. Conference of the Parties serving as the meeting of the Parties to the Protocol

The Conference of the Parties shall sit as the Meeting of the Parties to the Protocol.

2. Parties to the Convention which are not Parties to the Protocol may participate as observers in the work of any meeting of the Conference of the Parties serving as the Meeting of the Parties to the Protocol. Where the Conference of the Parties is a meeting of the Parties to the Protocol, decisions taken under the Protocol shall be made only by the Parties to the Protocol.

3. Where the Conference of the Parties sits as a Meeting of the Parties to the Protocol, any member of the Bureau of the Conference of the Parties representing a Party to the Convention that is not yet a Party to the Protocol shall be replaced by a new member Which is elected by the Parties to the Protocol among them.

4. The Conference of the Parties serving as the Meeting of the Parties to the Protocol shall monitor the implementation of the Protocol and shall, within the framework of its mandate, take the decisions necessary to promote its effective implementation. It shall perform the functions assigned to it by the Protocol and shall:

A.
Makes recommendations on any matter relating to the implementation of the Protocol;
B.
Establish the subsidiary bodies deemed necessary for the implementation of the Protocol;
C.
Appeals and uses, as appropriate, the services, cooperation and information provided by international organizations and relevant intergovernmental and non-governmental bodies;
D.
Determines the presentation and periodicity of the transmission of the information to be communicated pursuant to Art. 33 of the Protocol and reviews such information and the reports submitted by its subsidiary bodies;
E.
Consider and adopt, as appropriate, the amendments to the Protocol and its annexes, as well as any new annexes to the Protocol, deemed necessary for its implementation; and
F.
Exercise any other function that may be required by the application of the Protocol.

5. The rules of procedure of the Conference of the Parties and the financial rules of the Convention shall apply Mutatis mutandis The Protocol, unless the Conference of the Parties serving as the Meeting of the Parties to the Protocol decides otherwise by consensus.

The first meeting of the Conference of the Parties to the Convention sitting as the Meeting of the Parties to the Protocol shall be convened by the Secretariat at the same time as the first meeting of the Conference of the Parties to be held after the date Entry into force of the Protocol. Thereafter, the ordinary meetings of the Conference of the Parties serving as the Meeting of the Parties to the Protocol shall be held at the same time as the ordinary meetings of the Conference of the Parties, unless the Conference of the Parties sitting As a Meeting of the Parties to the Protocol shall not decide otherwise.

7. Extraordinary meetings of the Conference of the Parties serving as the Meeting of the Parties to the Protocol may take place at any other time if the Conference of the Parties serving as the Meeting of the Parties to the Protocol deems it Or at the written request of a Party, provided that this request is supported by at least one third of the Parties within six months of its submission to the Parties by the Secretariat.

8. The United Nations, its specialized agencies and the International Atomic Energy Agency, as well as any member State of such organizations or any observer to such organizations that is not a Party to the Convention, May be represented as an observer at the meetings of the Conference of the Parties serving as the Meeting of the Parties to the Protocol. Any body or institution, whether national or international, governmental or non-governmental, competent in areas covered by this Protocol and having informed the Secretariat of its wish to be represented as an observer At a meeting of the Conference of the Parties serving as the Meeting of the Parties to the Protocol, may be admitted in that capacity unless at least one third of the Parties present oppose it. The admission and participation of observers shall be governed by the rules of procedure referred to in paragraph 1. 5 above, except as otherwise provided in this Article.

Art. Subsidiary bodies

(1) Any subsidiary body established by or under the Convention may, by decision of the Conference of the Parties serving as the Meeting of the Parties to this Protocol, perform functions under the Protocol, in which case the Meeting of the Parties Parties shall specify the functions performed by that body.

(2) Parties to the Convention which are not Parties to this Protocol may participate, as an observer, in the work of any meeting of a subsidiary body of the Protocol. Where a subsidiary body of the Convention acts as a subsidiary body of the Protocol, decisions under the Protocol shall be taken only by the Parties to the Protocol.

Where a subsidiary body of the Convention performs its functions as a subsidiary body of the Protocol, any member of the Bureau of that subsidiary body representing a Party to the Convention that is not yet a Party to the Protocol shall be replaced By a new member who is elected by the Parties to the Protocol among them.

Art. Secretariat

1. The Secretariat established pursuant to s. 24 of the Convention shall act as the Secretariat of this Protocol.

2. Le par. 1 of the art. 24 of the Convention on the functions of the Secretariat applies Mutatis mutandis To this Protocol.

3. As far as they are distinct, the costs of the secretariat services relating to this Protocol shall be borne by the Parties to the Protocol. The Conference of the Parties serving as the Meeting of the Parties to the Protocol shall, at its first meeting, take the financial provisions necessary for that purpose.

Art. 32 Relations with the Convention

Except as otherwise provided in this Protocol, the provisions of the Convention relating to its Protocols shall apply to this Instrument.

Art. 33 Monitoring and reporting

Each Party shall ensure compliance with its obligations under this Protocol and, at regular intervals decided by the Conference of the Parties serving as the Meeting of the Parties to the Protocol, shall report to the Conference Parties serving as the Meeting of the Parties to the Protocol on the measures it has taken to implement the provisions of the Protocol.

Art. 34 Compliance with obligations

The Conference of the Parties serving as the Meeting of the Parties to the Protocol shall review and approve, at its first meeting, procedures and institutional mechanisms for cooperation to encourage compliance with the provisions of the Protocol and Treat cases of non-compliance. These procedures and mechanisms include provisions to provide advice or assistance, as appropriate. They are distinct and without prejudice to the procedure and dispute resolution mechanisms established under s. 27 of the Convention.

Art. 35 Evaluation and Review

The Conference of the Parties serving as the Meeting of the Parties to the Protocol shall proceed, five years after the entry into force of the Protocol, and thereafter at least every five years, to an assessment of its effectiveness, including an assessment of its Procedures and annexes.

Art. 36 Signature

This Protocol shall be open for signature by States and regional economic integration organizations at the United Nations Office at Nairobi from 15 to 26 May 2000, and at United Nations Headquarters in New York from 5 June 2000 to 4 June 2001.

Art. Entry into force

(1) This Protocol shall enter into force on the ninetieth day after the date of deposit of the fiftieth instrument of ratification, acceptance, approval or accession by States or regional economic integration organizations Who are Parties to the Convention.

(2) This Protocol shall enter into force for a State or a regional economic integration organization which ratifies, accepts, approves or accedes to it after its entry into force in accordance with par. 1 above, that is, the ninetieth day after the date of the deposit, by that State or economic integration organization, of its instrument of ratification, acceptance, approval or accession, or at the time when the Convention enters into force Effective for that State or regional economic integration organization, whichever is later.

3. For the purposes of paras. 1 and 2 above, none of the instruments deposited by a regional economic integration organization is considered to be in addition to the instruments already deposited by the member States of that organisation.

Art. 38 Reservations

No reservations may be made to this Protocol.

Art. 39 Denunciation

At the expiration of two years from the date of entry into force of this Protocol in respect of a Party, that Party may denounce the Protocol by written notification to the Depositary.

(2) Such denunciation shall take effect upon the expiration of one year from the date of its receipt by the Depositary, or at any later date which may be specified in the said notification.

Art. 40 Authentic texts

The original of this Protocol, of which the Arabic, Chinese, English, French, Russian and Spanish texts are equally authentic, shall be deposited with the Secretary-General of the United Nations.

In witness whereof, The undersigned, to that duly authorized, have signed this Protocol.

Done at Montréal, twenty-nine January two thousand.

(Suivent signatures)

Annex I

Information to be included in the notifications to be submitted in accordance with Art. 8, 10, and 13

A.
Name, address and contact information of the exporter.
B.
Name, address and contact details of the importer.
C.
Name and identity of the living modified organism and its classification according to the degree of biological safety, in the State of export, if it exists.
D.
Expected date or dates of transboundary movement if known.
E.
Common name and taxonomy, point of collection or acquisition, and characteristics of the receiving organism or parent organisms relevant to the prevention of biotechnological risks.
F.
Centres of origin and centres of genetic diversity, when known, of the receiving organism and/or parent organisms, and description of habitats where organisms may persist or proliferate.
G.
Common name and taxonomy, point of collection or acquisition, and characteristics of the organism or donor agencies relevant to the prevention of biotechnological risks.
H.
Description of the nucleic acid or modification introduced, the technique used, and the characteristics of the resulting modified living organism.
I.
Intended use of the living modified organism or the products derived from it, i.e. the transformed material originating from the living modified organism, which contains new detectable combinations of replicable genetic material obtained The use of modern biotechnology.
J.
The quantity or volume of living modified organisms to be transferred.
K.
Pre-existing risk assessment report in accordance with Annex III.
L.
Proposed methods for safe handling, storage, transportation and use, including packaging, labelling, documentation, disposal methods and procedures to be followed in an emergency, if applicable.
M.
Situation of the living modified organism in relation to the regulations in the State of export (p. If it is prohibited in the exporting State, if there are other restrictions, or if its general circulation has been authorised); if the living modified organism is prohibited in the exporting State, the reason (s) of that prohibition.
N.
The result and object of any notification by the exporter to other States concerning the living modified organism to be transferred.
O.
Declaration that the above information is accurate.

Status on February 3, 2015

Annex II

Information to be provided for any living modified organism intended to be used directly for human or animal feed, or to be processed, in accordance with s. 11

A.
The name and contact information of the person requesting permission for use on the national territory.
B.
The name and contact details of the authority responsible for the decision.
C.
The name and identity of the living modified organism.
D.
A description of the genetic modification, the technique used, and the characteristics of the resulting modified living organism.
E.
Any unique identification of the living modified organism.
F.
Taxonomy, common name, point of collection or acquisition, and characteristics of the receiving organism or parent organisms relevant to the prevention of biotechnological risks.
G.
The centres of origin and centres of genetic diversity, when known, of the receiving organism and/or parent organisms, and a description of habitats where organisms may persist or proliferate.
H.
Taxonomy, common name, point of collection and acquisition, and characteristics of the organism or donor agencies relevant to the prevention of biotechnological risks.
I.
The authorized uses of the living modified organism.
J.
A risk assessment report that is consistent with Annex III.
K.
Proposed methods for safe handling, storage, transportation and use, including packaging, labelling, documentation, disposal methods and emergency procedures, where applicable.

Status on February 3, 2015

Annex III

Risk Assessment

Objective

For the purposes of this Protocol, the purpose of the risk assessment is to identify and assess the potential adverse effects of living modified organisms on the conservation and sustainable use of biological diversity in the environment Potential receptor, taking into account also risks to human health.

Use of risk assessments

2. The risk assessment shall be used, inter alia, by the competent authorities to make an informed decision concerning living modified organisms.

General Principles

3. The risk assessment should be based on sound scientific methods and transparency and may take into account technical advice and guidance from relevant international organizations.

4. Do not necessarily deduce from the absence of scientific knowledge or consensus the seriousness of a risk, the absence of risk, or the existence of an acceptable risk.

5. The risks associated with living modified organisms or products derived from them, namely, transformed material from living modified organisms that contains new detectable combinations of replicable genetic material obtained Through the use of modern biotechnology, should be considered in relation to the risks posed by unmodified receptor or parent organisms in the likely potential receiving environment.

6. The risk assessment should be done on a case-by-case basis. The nature and degree of accuracy of the information required may vary, depending on the case, depending on the affected living organism affected, its intended use, and the likely potential receiving environment.

Methods

7. Risk assessment may require additional information on specific issues, which may be defined and requested during the evaluation; however, information on other issues may not be relevant. In some cases.

8. In order to achieve its objective, the risk assessment will include, where appropriate, the following steps:

A.
Identification of any novel genotypic and phenotypic characteristics associated with the modified living organism that may adversely affect biological diversity in the likely potential receiving environment, and also include Risks to human health;
B.
The assessment of the likelihood that these adverse effects will occur, taking into account the degree and type of exposure of the likely receiving environment of the living modified organism
C.
Assessing the consequences of these adverse effects if they were to occur;
D.
The estimate of the overall risk presented by the living modified organism on the basis of the assessment of the probability of occurrence of the adverse effects identified and their consequences;
E.
A recommendation as to whether the risks are acceptable or manageable, including, where appropriate, the identification of strategies for managing these risks; and
F.
Where there is uncertainty about the severity of the risk, additional information on specific areas of concern, or implementation of appropriate risk management strategies and/or control of the living organism, may be requested Modified in the receiving environment.

Items to be considered

9. Depending on the case, the risk assessment takes into account relevant technical and scientific data concerning:

A.
The receiving organization or parent organizations: The biological characteristics of the receiving body or parent organisms, including details concerning the taxonomy, common name, origin, centres of origin and centres of genetic diversity, when known, and Description of the habitat where organisms can persist or proliferate;
B.
The donor agency or agency: Taxonomy and common name, source and relevant biological characteristics of donor agencies;
C.
The vector: The characteristics of the vector, including its identity, if any, its source or origin, and the ranges of its hosts;
D.
Insert or insert and/or modification characteristics: The genetic characteristics of the inserted nucleic acid and the function it determines, and/or the characteristics of the introduced modification;
E.
The living modified organism: Identity of the living modified organism, and differences between the biological characteristics of the living modified organism and those of the receiving organism or parent organisms;
F.
The detection and identification of the living modified organism: Proposed detection and identification methods and their specificity, accuracy and reliability;
G.
Information on intended use: Information on the intended use of the living modified organism, including any new use or use that is different from that of the receiving or parent organization; and
H.
Receiving environment: Information on the location and geographic, climatic and ecological characteristics of the potential receiving environment, including relevant information on biological diversity and the centres of origin found there.

Status on February 3, 2015

Scope of application February 3, 2015 3

States Parties

Ratification

Accession (A)

Entry into force

Afghanistan

20 February

2013 A

21 May

2013

South Africa

August 14

2003 A

12 November

2003

Albania

February 8

2005 A

9 May

2005

Algeria

August 5

2004

3 November

2004

Germany

20 November

2003

18 February

2004

Angola

February 27

2009 A

28 May

2009

Antigua and Barbuda

10 September

2003

9 December

2003

Saudi Arabia

August 9

2007 A

7 November

2007

Armenia

April 30

2004 A

July 29

2004

Austria

August 27

2002

11 September

2003

Azerbaijan

1 Er April

2005 A

30 June

2005

Bahamas

15 January

2004

April 14

2004

Bahrain

7 February

2012 A

7 May

2012

Bangladesh

5 February

2004

5 May

2004

Barbados

September 6

2002 A

11 September

2003

Belarus

26 August

2002 A

11 September

2003

Belgium

15 April

2004

July 14

2004

Belize

12 February

2004 A

12 May

2004

Benin

2 March

2005

May 31

2005

Bhutan

26 August

2002 A

11 September

2003

Bolivia

22 April

2002

11 September

2003

Bosnia and Herzegovina

1 October

2009 A

December 30

2009

Botswana

11 June

2002

11 September

2003

Brazil

24 November

2003 A

22 February

2004

Bulgaria

13 October

2000

11 September

2003

Burkina Faso

August 4

2003

2 November

2003

Burundi

2 October

2008 A

31 December

2008

Cambodia

September 17

2003 A

16 December

2003

Cameroon

20 February

2003

11 September

2003

Cape Verde

1 Er November

2005 A

30 January

2006

China A

8 June

2005

September 6

2005

Hong Kong

9 May

2011

9 May

2011

Cyprus

5 December

2003 A

March 4

2004

Colombia

20 May

2003

11 September

2003

Comoros

25 March

2009 A

23 June

2009

Congo (Brazzaville)

July 13

2006

11 October

2006

Congo, Kinshasa

23 March

2005 A

21 June

2005

Korea (North)

July 29

2003

27 October

2003

Korea (South)

3 October

2007

1 Er January

2008

Costa Rica

February 6

2007

7 May

2007

Croatia

29 August

2002

11 September

2003

Cuba

September 17

2002

11 September

2003

Denmark B

August 27

2002

11 September

2003

Djibouti

April 8

2002 A

11 September

2003

Dominica

July 13

2004 A

11 October

2004

Egypt

December 23

2003

22 March

2004

El Salvador

26 September

2003

25 December

2003

United Arab Emirates

12 September

2014 A

11 December

2014

Ecuador

30 January

2003

11 September

2003

Eritrea

10 March

2005 A

8 June

2005

Spain *

16 January

2002

11 September

2003

Estonia

24 March

2004

22 June

2004

Ethiopia

9 October

2003

7 January

2004

Fiji

5 June

2001

11 September

2003

Finland

July 9

2004

7 October

2004

France

7 April

2003

11 September

2003

Gabon

2 May

2007 A

July 31

2007

Gambia

9 June

2004

7 September

2004

Georgia

4 November

2008 A

2 February

2009

Ghana

30 May

2003 A

11 September

2003

Greece

21 May

2004

19 August

2004

Grenada

5 February

2004

5 May

2004

Guatemala

28 October

2004 A

26 January

2005

Guinea

11 December

2007

10 March

2008

Guinea-Bissau

19 May

2010 A

August 17

2010

Guyana

18 March

2008 A

June 16

2008

Honduras

18 November

2008

February 16

2009

Hungary

13 January

2004

12 April

2004

Marshall Islands

27 January

2003 A

11 September

2003

India

17 January

2003

11 September

2003

Indonesia

3 December

2004

3 March

2005

Iraq

3 March

2014 A

1 Er June

2014

Iran

20 November

2003

18 February

2004

Ireland

14 November

2003

12 February

2004

Italy

24 March

2004

22 June

2004

Jamaica

September 25

2012

24 December

2012

Japan

21 November

2003 A

19 February

2004

Jordan

11 November

2003

February 9

2004

Kazakhstan

8 September

2008 A

7 December

2008

Kenya

24 January

2002

11 September

2003

Kyrgyzstan

5 October

2005 A

3 January

2006

Kiribati

20 April

2004

19 July

2004

Laos

August 3

2004 A

1 Er November

2004

Lesotho

September 20

2001 A

11 September

2003

Latvia

13 February

2004 A

13 May

2004

Lebanon

February 6

2013 A

7 May

2013

Liberia

February 15

2002 A

11 September

2003

Libya

14 June

2005 A

12 September

2005

Lithuania

7 November

2003

5 February

2004

Luxembourg

August 28

2002

11 September

2003

Macedonia

14 June

2005

12 September

2005

Madagascar

24 November

2003

22 February

2004

Malaysia

3 September

2003

2 December

2003

Malawi

February 27

2009

27 May

2009

Maldives

3 September

2002 A

11 September

2003

Mali

August 28

2002

11 September

2003

Malta

5 January

2007 A

5 April

2007

Morocco

April 25

2011

24 July

2011

Mauritius

April 11

2002 A

11 September

2003

Mauritania

July 22

2005 A

20 October

2005

Mexico

August 27

2002

11 September

2003

Moldova

March 4

2003

11 September

2003

Mongolia

July 22

2003 A

20 October

2003

Montenegro

23 October

2006 S

3 June

2006

Mozambique

21 October

2002

11 September

2003

Myanmar

13 February

2008

13 May

2008

Namibia

10 February

2005

11 May

2005

Nauru

12 November

2001 A

11 September

2003

Nicaragua

August 28

2002

11 September

2003

Niger

September 30

2004

29 December

2004

Nigeria

July 15

2003

13 October

2003

Niue

July 8

2002 A

11 September

2003

Norway

10 May

2001

11 September

2003

New Zealand C

24 February

2005

25 May

2005

Oman

April 11

2003 A

11 September

2003

Uganda

30 November

2001

11 September

2003

Pakistan

2 March

2009

May 31

2009

Palau

13 June

2003

11 September

2003

Palestine

2 January

2015 A

2 April

2015

Panama

1 Er May

2002

11 September

2003

Papua New Guinea

14 October

2005 A

12 January

2006

Paraguay

10 March

2004

8 June

2004

Netherlands

8 January

2002

11 September

2003

Peru

April 14

2004

July 13

2004

Philippines

5 October

2006

3 January

2007

Poland

10 December

2003

March 9

2004

Portugal

September 30

2004

29 December

2004

Qatar

March 14

2007 A

12 June

2007

Central African Republic

18 November

2008

February 16

2009

Dominican Republic

20 June

2006 A

18 September

2006

Czech Republic

8 October

2001

11 September

2003

Romania

30 June

2003

28 September

2003

United Kingdom

19 November

2003

17 February

2004

Gibraltar

30 May

2014

30 May

2014

Rwanda

July 22

2004

20 October

2004

Saint Lucia

June 16

2005 A

September 14

2005

Saint Kitts and Nevis

23 May

2001 A

11 September

2003

Saint Vincent and the Grenadines

August 27

2003 A

25 November

2003

Solomon Islands

28 July

2004 A

26 October

2004

Samoa

30 May

2002

11 September

2003

Senegal

8 October

2003

6 January

2004

Serbia

February 8

2006 A

9 May

2006

Seychelles

13 May

2004

August 11

2004

Slovakia

24 November

2003

22 February

2004

Slovenia

20 November

2002

11 September

2003

Somalia

26 July

2010 A

24 October

2010

Sudan

13 June

2005 A

11 September

2005

Sri Lanka

28 April

2004

26 July

2004

Sweden

8 August

2002

11 September

2003

Switzerland

26 March

2002

11 September

2003

Suriname

March 27

2008 A

25 June

2008

Swaziland

13 January

2006 A

13 April

2006

Syria

1 Er April

2004 A

30 June

2004

Tajikistan

12 February

2004 A

12 May

2004

Tanzania

24 April

2003 A

11 September

2003

Chad

1 Er November

2006

30 January

2007

Thailand

10 November

2005 A

February 8

2006

Togo

July 2

2004

September 30

2004

Tonga

18 September

2003 A

17 December

2003

Trinidad and Tobago

5 October

2000 A

11 September

2003

Tunisia

22 January

2003

11 September

2003

Turkmenistan

August 21

2008 A

19 November

2008

Turkey

24 October

2003

24 January

2004

Ukraine

6 December

2002 A

11 September

2003

European Union *

August 27

2002

11 September

2003

Uruguay

2 November

2011

31 January

2012

Venezuela

13 May

2002

11 September

2003

Vietnam

21 January

2004 A

20 April

2004

Yemen

1 Er December

2005 A

1 Er March

2006

Zambia

April 27

2004 A

July 25

2004

Zimbabwe

25 February

2005

26 May

2005

*
Reservations and declarations.
Reservations and declarations are not published in the RO. The texts in English and French can be found at the United Nations Internet site: http://treaties.un.org or obtained from the Directorate of Public International Law (DDIP), International Treaty Section, 3003 Berne.
A
China stated on 8 June 2005 that the Protocol did not apply to the Hong Kong and Macao Special Administrative Regions.
B
Territorial exclusion for the Faroe Islands and Greenland.

C The Protocol does not apply to Tokelau.


RO 2004 579 ; FF 2001 3884


1 RO 2004 577
2 RS 0.451.43
3 RO 2004 606 3713, 2005 2335, 2006 791 4451, 2007 1401, 2008 4121, 2010 17, 2011 4887, 2013 1485, 2015 591. A version of the updated scope of application is published on the DFAE website (www.dfae.admin.ch/traites).


Status on February 3, 2015